Senator Elizabeth Warren sounds off on Monsanto-Bayer merger

Screen Shot at PM

Back in September 2016, US agribusiness titan Monsanto and German chemical conglomerate Bayer agreed to a $66 billion merger, making way for a globe-spanning firm with huge shares of the world’s seed and pesticide markets. The deal remains unconsummated, still under scrutiny by antitrust authorities. Donald Trump signaled readiness to bless the deal before taking office, but his administration has been pretty silent about it since.

Enter Trump’s nemesis, Sen. Elizabeth Warren (D.-Mass.). In a recent speech before the Open Markets Institute, Warren denounced rising levels of corporate consolidation—massive companies merging into vast market-dominating entities that invest a share of their profits in lobbying and financing campaigns, shaping the political system to their own ends.

…

[Warren] called on the Trump administration to nix Bayer-Monsanto. “If the Bayer-Monsanto merger is approved, one gigantic company would supply one-quarter of the entire world’s seeds and pesticides,” she noted.

…

As Warren notes, the Trump administration has already blessed a similar merger between former rivals Dow and DuPont, which will eventually roll out a seed/agrichemical giant bigger than Monsanto at its current size. It also signed off on the takeover of Swiss pesticide giant and ChemChina.  If Monsanto/Bayer gets the green light as well, then just three corporations will own the lion’s share of the globe’s seed and pesticide markets, giving them enormous leverage over farmers worldwide.

Read full, original post: Elizabeth Warren Just Let Loose on Trump and Monsanto

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Professional Portrait Earth Backdrop
Viewpoint: November 13 is the long-predicted global doomsday. How a respected scientist got population growth catastrophe predictions so spectacularly wrong—fueling decades of junk science
ADA Lanyard on Woodgrain Desk
How the Trumpification of medicine is roiling — and maybe destroying—the American Diabetes Association
Tropical Yacht Conversation
Kennedy faces Congressional ethics investigation for accepting massive gifts from anti-vaccine and ketamine wellness grifter
Screenshot-2026-11-09-at-1.40.16-PM
As measles cases continue to surge, RFK Jr. blocks CDC scientists from issuing emergency alert warning unvaccinated pregnant women of significantly increased risks
Colorful GLP-1 Pens with Clocks_tagger
Biohacker influencers are claiming GLP-1 weight loss drugs extend lifespan. One mice experiment suggests there may be some truth to the claim
Vegan and Unvaxxed Salad Protest
Viewpoint: ‘Sanitation and nutrition not vaccines’: The rejectionists' latest false substitute for staying up to date on your shots
Paper Field Portraits with Distant Barn (1)
Viewpoint: After MAHA-Republican election debacle, controversial campaigner Zen Honeycutt looks to sympathetic Democrats to promote her anti-chemical agenda
Neon Binary Code Bacteriophage
AI medicine breakthrough: Could ‘good viruses’ created by AI cure deadly diseases and infections?
gmos africa
Slow adoption: Only 15 of Africa’s 54 nations embrace genetic engineering food revolution. Here’s why
Testosterone-and-NATO-Editorial-Collage
Unintended consequences: Hegseth’s proposed controversial ‘low testosterone’ screen could flag 150,000 Army men. What happens next?  
Screenshot-2026-11-09-at-3.01.19-PM
Are Texas data centers killing calves? Debunking viral AI claims
Data Center Power and Cost Surge
It’s the ‘juice’: What the AI data center wars are really all about
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.